The antibiotics in the chemical space

Current Medicinal Chemistry

Volumn 16, Issue 3, 2009, Pages 390-393

  Gualtieri, Maxime ^a   Banéres Roquet, Françoise ^a   Villain Guillot, Philippe ^a   Pugnière, Martine ^a   Leonetti, Jean Paul ^a  

^a University of Montpellier I and II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN; DIAZEPAM; DOXYCYCLINE; GLYCOPEPTIDE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFAMETHOXAZOLE; SULFANILAMIDE; TETRACYCLINE; WARFARIN; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; SERUM ALBUMIN;

DRUG DESIGN; DRUG INDUSTRY; DRUG STRUCTURE; ERADICATION THERAPY; HYDROPHILICITY; HYDROPHOBICITY; MOLECULAR LIBRARY; REVIEW; ANIMAL; BINDING SITE; CHEMISTRY; COMBINATORIAL CHEMISTRY; HUMAN; METABOLISM; PROTEIN BINDING;

ANIMALS; ANTI-BACTERIAL AGENTS; BINDING SITES; BIOLOGICAL PRODUCTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; HUMANS; PROTEIN BINDING; SERUM ALBUMIN;

EID: 61949464375     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709787002628     Document Type: Review

References (24)

1. Payne D.J.; Gwynn M.N.; Holmes D.J.; Pompliano, David L. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 2007, 6, 29-40.
2. Mills S.D. When will the genomics investment pay off for antibacterial discovery? Biochem. Pharmacol., 2006, 71, 1096-102.
3. Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods, 2000, 44, 235-249.
4. Ghuman, J.; Zunszain P.A.; Petitpas I.; Bhattacharya A.A.; Otagiri M.; Curry S. Structural Basis of the Drug-binding Specificity of Human Serum Albumin. J. Mol. Biol., 2005, 353, 38-52.
5. Zheng C.J.; Sun L.Z.; Han L.Y.; Ji X.; Chen Z.L.; Chen Y.Z. Drug ADME-associated protein database as a resource for facilitating pharmacogenomics research. Drug. Dev. Res., 2004, 62, 134-142.
6. Israili Z. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab. Rev., 2001, 33, 161-235.
7. Aki H.; Yamamoto M. Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry. J. Pharm. Sci., 1994, 83, 1712-1716.
8. Tawara S.; Matsumoto S.; Matsumoto Y.; Kamimura T.; Goto S. Structure-binding relationship and binding sites of cephalosporins in human serum albumin. J. Antibiot. (Tokyo), 1992, 45, 1346-1357.
9. Hasan, S. Interaction of doxycycline and warfarin: An enhanced anticoagulant effect. Cornea, 2007, 26, 742-743
10. Tilstone W.; Gray J.M.; Nimmo-Smith R.H.; Lawson D.H. Interaction between warfarin and sulphamethoxazole. Postgrad. Med. J., 1977, 53, 388-390.
11. McNamara P.J.; Trueb V.; Stoeckel K. Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam. Biochem. Pharmacol., 1990, 40, 1247-53.
12. Peterson L.. Hall W.H.; Zinneman H.H.; Gerding D.N. Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics. J. Infect. Dis., 1977, 136, 778-783.
13. Boman G.; Ringberger V.A. Binding of rifampicin by human plasma proteins. Eur. J. Clin. Pharmacol., 1974, 7, 369-73.
14. Johnson D.A.; Smith K.D. The efficacy of certain anti-tuberculosis drugs is affected by binding to alpha-1-acid glycoprotein. Biomed. Chromatogr., 2006, 20, 551-560.
15. Powis G.A. A study of the interaction of tetracycline with human serum lipoproteins and albumin. J. Pharm. Pharmacol., 1974, 26, 113-118.
16. Rolinson G.N. The significance of protein binding of antibiotics in antibacterial chemotherapy. J. Antimicrob. Chemother., 1980, 6, 311-317.
17. Gunderson B.; Ross G.H.; Ibrahim K.H.; Rotschafer J.C. What do we really know about antibiotic pharmacodynamics? Pharmacotherapy, 2001, 21, 302S-318S.
18. Kennedy T. Managing the drug discovery/development interface. Drug Discov. Today, 1997, 2, 436-444.
19. Bérdy J. Bioactive Microbial Metabolites. J. Antibiot. (Tokyo), 2005, 58, 1-26.
20. Walsh, C.T.; Combinatorial Biosynthesis of Antibiotics: Challenges and Opportunities. ChemBioChem, 2002, 3, 124-134.
21. Williams G.J.; Zhang C.; Thorson J.S. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution Nat. Chem. Biol., 2007, 3, 657-62.
22. Fu X.; Albermann C.; Jiang J.; Liao J.; Zhang C.; Thorson J.S. Antibiotic optimization via in vitro glycorandomization. Nat. Biotech., 2003, 21, 1467-9.
23. van Hellemond, EW, Janssen DB, Fraaije MW. Discovery of a Novel Styrene Monooxygenase Originating from the Metagenome. Appl. Environ. Microbiol., 2007, 73, 5832-5839.
24. Bernhardt R. Cytochromes P450 as versatile biocatalysts. J. Biotechnol., 2006, 124, 128-45.